Skye Bioscience, Inc. Common Stock Working Capital to Net Assets Ratio
Skye Bioscience, Inc. Common Stock working capital to net assets ratio. Skye Bioscience, Inc. Common Stock (SKYE) has a Working Capital to Net Assets ratio of 115.1% as of June 2026. Working capital of $-572.22K (current assets of $10.96 Million minus current liabilities of $11.53 Million) is measured against net assets of $-497.31K. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Skye Bioscience, Inc. Common Stock tangible book value ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Skye Bioscience, Inc. Common Stock (2012–2025)
Working capital to net assets ratio of Skye Bioscience, Inc. Common Stock from 2012 to 2025. This chart shows how Skye Bioscience, Inc. Common Stock's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of June 2026, the ratio stands at 115.1%, reflecting working capital of $-572.22K against net assets of $-497.31K USD. See how many days can Skye Bioscience, Inc. Common Stock fund operations to measure how many days the company can operate on defensive assets alone.
Skye Bioscience, Inc. Common Stock Working Capital to Net Assets Ratio by Year (2012–2025)
Skye Bioscience, Inc. Common Stock working capital to net assets ratio by year from 2012 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Skye Bioscience, Inc. Common Stock from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see SKYE asset base.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 94.3% | $18.89 Million | $20.02 Million | $27.09 Million | $8.21 Million | ▼ -3.2 pp |
| 2024 | 97.6% | $66.49 Million | $68.15 Million | $70.83 Million | $4.34 Million | ▼ -8.0 pp |
| 2023 | 105.6% | $-2.25 Million | $-2.13 Million | $11.65 Million | $13.90 Million | ▼ 0.0 pp |
| 2022 | 105.6% | $-3.18 Million | $-3.01 Million | $8.94 Million | $12.12 Million | ▲ +8.4 pp |
| 2021 | 97.2% | $5.70 Million | $5.86 Million | $9.61 Million | $3.91 Million | ▼ -319.2 pp |
| 2020 | 416.4% | $1.88 Million | $450.79K | $2.66 Million | $787.20K | ▲ +229.6 pp |
| 2019 | 186.8% | $1.02 Million | $548.06K | $1.99 Million | $970.82K | ▲ +97.0 pp |
| 2018 | 89.9% | $-13.99 Million | $-15.56 Million | $1.95 Million | $15.94 Million | ▲ +58.6 pp |
| 2017 | 31.3% | $-250.16K | $-800.08K | $555.81K | $805.97K | ▲ +4.9 pp |
| 2016 | 26.4% | $-382.47K | $-1.45 Million | $279.49K | $661.96K | ▼ -583.4 pp |
| 2015 | 609.8% | $2.87 Million | $471.00K | $3.45 Million | $581.86K | ▲ +501.1 pp |
| 2014 | 108.6% | $-492.69K | $-453.55K | $308.40K | $801.09K | ▼ -99.9 pp |
| 2013 | 208.5% | $-76.02K | $-36.46K | $106.13K | $182.15K | ▲ +120.3 pp |
| 2012 | 88.2% | $34.02K | $38.56K | $38.35K | $4.33K | — |